Net sales for DJO’s bracing and vascular segment increased 9.6 percent in the third quarter, while net sales for the recovery sciences segment fell by 1.3 percent. The company’s surgical implant segment saw a 12.9 percent increase to $17.2 million.
More Articles on Orthopedic Devices:
Smith & Nephew Launches Endobutton
DSM, AxioMed Partner for Freedom Spine Device
MiMedx 3Q Revenue Grows 270% to $8M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.